Minocycline in phenotypic models of Huntington's disease

Minocycline in phenotypic models of Huntington's disease

Minocycline has been shown to be neuroprotective in various models of neurodegenerative diseases. However, its potential in Huntington's disease (HD) models characterized by calpain-dependent degeneration and inflammation has not been investigated. Here, we have tested minocycline in phenotypic...

Full description

Bibliographic Details
Main Authors:	Kadiombo Bantubungi, Carine Jacquard, Anita Greco, Annita Pintor, Abdelwahed Chtarto, Khalid Tai, Marie-Christine Galas, Liliane Tenenbaum, Nicole Déglon, Patrizia Popoli, Luisa Minghetti, Emmanuel Brouillet, Jacques Brotchi, Marc Levivier, Serge N. Schiffmann, David Blum
Format:	Article
Language:	English
Published:	Elsevier 2005-02-01
Series:	Neurobiology of Disease
Subjects:	Huntington's disease 3-Nitropropionic acid Quinolinic acid Minocycline Striatum Cell death
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996104002311

Similar Items

Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms
by: Marie-Christine Galas, et al.
Published: (2004-02-01)

Clinical potential of minocycline for neurodegenerative disorders
by: David Blum, et al.
Published: (2004-12-01)

Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington’s disease
by: Pradeep Singh, et al.
Published: (2022-05-01)

3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future
by: Abel Santamaría, et al.
Published: (2010-02-01)

Experience of experimental simulation of Huntington’s disease
by: A. V. Stavrovskaya, et al.
Published: (2017-02-01)

Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons
by: Barbara Picconi, et al.
Published: (2006-04-01)

Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegeneration
by: Paula Dietrich, et al.
Published: (2022-01-01)

Worsening of Huntington disease phenotype in CB1 receptor knockout mice
by: Stéphane Mievis, et al.
Published: (2011-06-01)

Transplantation of neuronal precursors derived from induced pluripotent stem cells into the striatum of rats with the toxin-induced model of Huntington’s disease
by: Alla V. Stavrovskaya, et al.
Published: (2017-02-01)

Anti-inflammatory effects of minocycline are mediated by retinoid signaling
by: Vera Clemens, et al.
Published: (2018-09-01)

Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease
by: Jae K Ryu, et al.
Published: (2004-06-01)

Neuroprotectant Effects of Hibiscetin in 3-Nitropropionic Acid-Induced Huntington’s Disease via Subsiding Oxidative Stress and Modulating Monoamine Neurotransmitters in Rats Brain
by: Wael A. Mahdi, et al.
Published: (2023-02-01)

Pigmentary and Other Dermatologic Manifestations of Minocycline: a reminder of adverse effects
by: Kayla Rodriguez, et al.
Published: (2019-10-01)

Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
by: Jung-Eun Park, et al.
Published: (2013-10-01)

Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future
by: Arezoo Asadi, et al.
Published: (2020-09-01)

Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington’s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms
by: Pei Teng Lum, et al.
Published: (2023-07-01)

Effect of Shorea robusta resin extract in 3-nitropropionic acid-induced Huntington's disease symptoms in Sprague-Dawley rats
by: Chirag Patel, et al.
Published: (2023-01-01)

Comparison of efficacy of oral azithromycin with oral minocycline in the treatment of acne vulgaris
by: Vidyadhar R Sardesai, et al.
Published: (2017-01-01)

A Case of Granuloma Faciale Successfully Treated with Minocycline
by: Liu L, et al.
Published: (2023-08-01)

Minocycline prevents hypoxia-induced seizures
by: Isato Fukushi, et al.
Published: (2023-03-01)

The therapeutic role of minocycline in Parkinson’s disease
by: Seyda Cankaya, et al.
Published: (2019-03-01)

A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea
by: Ana M. Martins, et al.
Published: (2021-06-01)

Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease
by: Shilpa Ramaswamy, et al.
Published: (2007-05-01)

The Role of Minocycline in Neuro-Cognitive Symptoms in the Episodes of Primary Psychosis: A Clinical Trial
by: Abolfazl Ghoreishi, et al.
Published: (2020-08-01)

Staining of palatal torus secondary to long term minocycline therapy
by: Buddula Aravind
Published: (2009-01-01)

Anti-Huntington’s Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents
by: Muhammad Afzal, et al.
Published: (2022-07-01)

Mycotoxins and Other Secondary Metabolites Are Produced by <i>Gnomoniopsis smithogilvyi</i> When Confronted with Biological and Chemical Control Agents
by: Micaela Álvarez, et al.
Published: (2023-05-01)

Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid
by: Calderón Guzmán David, et al.
Published: (2016-09-01)

Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism
by: Jai Malik, et al.
Published: (2017-01-01)

Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease
by: Maddalena Napolitano, et al.
Published: (2004-03-01)

Europinidin Mitigates 3-NPA-Induced Huntington’s Disease Symptoms in Rats: A Comprehensive Analysis of Oxidative Stress, Mitochondrial Enzyme Complex Activity, Pro-Inflammatory Markers and Neurotransmitter Alterations
by: Khalid Saad Alharbi
Published: (2024-03-01)

Testicular Pain Associated With Minocycline Use
by: Victor Kucherov, et al.
Published: (2015-05-01)

Protective Effect of Minocycline Against Cisplatin-induced Ototoxicity
by: Chi-Kyou Lee, et al.
Published: (2011-06-01)

Minocycline reduces reactive gliosis in the rat model of hydrocephalus
by: Xu Hao, et al.
Published: (2012-12-01)

Anti-apoptotic effects of minocycline on doxorubicin-induced cardiotoxicity in male Wistar rats
by: Hossein Piri, et al.
Published: (2023-12-01)

Preparation and release characteristics study on the novel minocycline hydrochloride sustained-release capsule
by: Songfeng Zhao, et al.
Published: (2016-02-01)

Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro
by: Tingting Guo, et al.
Published: (2022-09-01)

Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington's disease in rats
by: Navneet Kaur, et al.
Published: (2015-01-01)

Mesotherapy-Induced Cutaneous Foreign Body-Type Granulomatous Reaction in the Face Treated with Minocycline: Case Report and Literature Review
by: Zhang Q, et al.
Published: (2023-04-01)

Floating tablets of minocycline hydrochloride: Formulation, in-vitro evaluation and optimization
by: Ali Raza, et al.
Published: (2017-12-01)